Hemab Therapeutics Holdings, Inc. (COAG): SCHEDULE 13G filed Aug 12, 2026

Name: Hemab Therapeutics Holdings, Inc. SCHEDULE 13G (0001562230-26-000124)
Creator: Hemab Therapeutics Holdings, Inc.
Published: 2026-08-12

Form type: SCHEDULE 13G
Filing date: Aug 12, 2026
Accession number: 0001562230-26-000124
Filer: Hemab Therapeutics Holdings, Inc. (CIK 2114044)